Approvals/TGA/NOVOMIX 30 FLEXPEN 3mL 30% soluble insulin aspart (rys) and 70% insulin aspart (rys) crystallised with protamine 300U/3mL injection syringe

Approved

STANDARD

NOVOMIX 30 FLEXPEN 3mL 30% soluble insulin aspart (rys) and 70% insulin aspart (rys) crystallised with protamine 300U/3mL injection syringe

Novo Nordisk Pharmaceuticals Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Date: May 30, 2025
Approval ID: 2639e13747e6614c
Company: Novo Nordisk Pharmaceuticals Pty Ltd
Type: Standard

Approval Details

Approval Id: 2639e13747e6614c
Product Name: NOVOMIX 30 FLEXPEN 3mL 30% soluble insulin aspart (rys) and 70% insulin aspart (rys) crystallised with protamine 300U/3mL injection syringe
Artg Id: 143166
Artg Name: NOVOMIX 30 FLEXPEN 3mL 30% soluble insulin aspart (rys) and 70% insulin aspart (rys) crystallised with protamine 300U/3mL injection syringe
Sponsor: Novo Nordisk Pharmaceuticals Pty Ltd
Company Detail Path: /organization/novo-nordisk-pharmaceuticals-pty-limited
Artg Date: 2008-06-05
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: https://medical-cdn.nocode.com/drug_tga/5d21f6019c3f11ecdc47cc6d5d4141cf.pdf
Product Information: https://medical-cdn.nocode.com/drug_tga/d43f4b371c6b2c7a7e943d9fe2762a71.pdf

Active Ingredients

Approved

Quick Info

Agency

TGA

Country

🇦🇺

Approval Date

May 30, 2025

Approval ID

2639e13747e6614c

Type

Standard

Back to TGA Approvals